Hepatitis C screening in chronic haemodialysis patients in France: A physician practice pattern study;Etude nationale des pratiques de depistage de l'hepatite C chez les patients hemodialyses

Nephrologie

Volumn 19, Issue 4, 1998, Pages 217-222

  Ducret, N ^a   Mercier, S ^a   Colin, C ^a   Vergnon, P ^a   Laroche, C ^a   Bailly, F ^a   Caillette, A ^b   Labeeuw, M ^c   Trepo, C ^a  

^a HÔTEL DIEU   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Haemodialysis; Hepatitis C; Practice study; Screening

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL PRACTICE; FRANCE; HEMODIALYSIS; HEPATITIS C; HUMAN; QUESTIONNAIRE; SCREENING TEST; SEROLOGY; VIRUS DETECTION;

ADULT; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; BLOOD TRANSFUSION; COMORBIDITY; COST-BENEFIT ANALYSIS; FEMALE; FRANCE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOLOGIC TECHNIQUES; INTERFERONS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVER; MALE; MASS SCREENING; MIDDLE AGED; NEPHROLOGY; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; QUESTIONNAIRES; RENAL DIALYSIS; SEROEPIDEMIOLOGIC STUDIES; SEROLOGIC TESTS; TRAVEL;

EID: 0031779068     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Desenclos JC, Drucker J, et le groupe de l'action concertée hépatite C. Action concertée sur l'épidémiologie de l'hépatite C : résultats et propositions. Réseau national de santé publique, octobre 1995.
2. Nalpas B, Delarocque-Astagneau E, Desenclos JC. European survey on hepatitis C. Réseau national de santé publique, décembre 1996.
3. Di Bisceglie AM, Goodman ZD, Ishak KG. Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991; 6: 969-74.
4. Koretz RL, Stone O, Mousa M, Gitnick GL. Non-A, non-B post-transfusion hepatitis : A decade later. Gastroenterology 1985; 88: 1251-4.
5. Realdi G, Alberti A, Rugge M, Rigoli A, Tremolada F, Schiwazappa L, et al. Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis : Evidence of progression to liver cirrhosis. Gut 1982; 23: 270-5.
6. Consensus Conférence. Hépatitis C. Screening and treatment. Gastroenterol Clin Biol 1997; 21: 45-9.
7. Poynard T, Leroy V, Cohard M, Thévenot T, Mathurin P, Opolon P, et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C. Effects of dose and duration. Hepatology 1996; 24: 778-89.
8. Rafaella R, Pol S, Berthelmot P, Brechot C. Eradication of hepatitis C virus RNA after alpha-Interferon therapy. Ann Int Med 1994; 121: 276-7.
9. Reichard O, Glaumann H, Fryden A, Norkrans G, Schvarcz R, Sonnerborg A, et al. Two-year biochemical, virological and histological follow-up in patients with chronic hepatitis C responding to Interferon alfa-2b treatment. Hepatology 1995; 21: 918-22.
10. Pol S, Romeo R, Zins B, Driss F, Lebkiri B, Carnot F, et al. Hepatitis C virus (HCV) RNA in anti-HCV positive hemodialysed patients significance and therapeutic implications. Kidney Int 1993; 44: 1097-100.
11. Chauveau P, Bouchardeau F, Couroucé AM, Lemarrec N, Naret C, Poignet JL, et al. Antibodies to hepatitis C virus infection by second generation test in hemodialysed patients. Kidney Int 1993; 43: 5149-52.
12. Busch MP, Korelitz JJ, Kleinman SH, Lee SR, Aubuchon JP, Schreiber GB, and the Retrovirus epidemiology donor study. Declining value of alanine aminotransferase in screening of blood donors to prevent post-transfusion hepatitis B and C virus infection. Transfusion 1995; 35: 903-10.
13. Wolff C, Kleesiek K, Petersen N, Beyer J. Hepatitis C viremia in german blood donors: Serum alanine aminotransferase is not a valid marker for screening. Transfusion 1994; 34: 361-2.
14. Dubois F, François M, Mariotte N, Caces E, Vol S, Roingeard P, et al. Serum alanine aminotransferase measurement as a guide to selective testing for hepatitis C during medical checkup. J Hepatol 1994; 21: 837-41.
15. Donahue JG, Munoz A, Ness PM, Brown DE, Yawn DH, Mc Allister HA, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327: 369-73.
16. Couroucé AM, Le Marrec N, Girault A, Ducamp S, Simon N. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis : Comparison of second- and third-generation anti-HCV assays. Transfusion 1994; 34: 790-5.
17. Couroucé AM, Barin F, Botte C, Lunel F, Maisonneuve P, Maniez M, et al. A comparative evaluation of the sensitivity of seven anti-hepatitis C virus screening tests. Vox Sang 1995; 69: 213-6.
18. Stuyver L, Claeys H, Wyseur A, Van Arnhem W, De Beenhouwer H, Uytendaele S, et al. Hepatitis C virus in a hemodialysis unit : Molecular evidence for nosocomial transmission. Kidney Int 1996; 49: 889-95.
19. Kaur S, Rybicki L, Bacon BR, Gollan JL, Rustgi VK, Carey WD, and the National hepatitis surveillance group. Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral hepatitis B and C : Results of the national hepatitis screening survey. Hepatology 1996; 24: 979-86.
20. Couroucé AM, Bouchardeau F, Chauveau P, Le Marrec N, Girault A, Zins B, Naret C, Poignet JL. Hepatitis C virus (HCV) infection in haemodialysed patients : HCV-RNA and anti-HCV antibodies (third-generation assays). Nephrol Dial Transplant 1995; 10: 234-9.
21. Meshari KA, Alfurayh O, Ahdal MA, Qunibi W, Kessie G, De Vol E. Hepatitis C virus infection in haemodialysis patients: Comparison of two new hepatitis C antibody assays with a second-generation assay. J Am Soc Nephrol 1995; 6: 1439-44.
22. De Medina M, Schiff ER, Hepatitis C: Diagnostic assays. Semin Liver Dis 1995; 15: 33-40.
23. Dussaix E, Charnaux N, Laurent-Puig P, Chopineau S, Laurian Y, Buffet C. Analysis of sera indeterminate by Ortho-HCV RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibody. J Clin Microbiol 1994; 32: 2071-5.
24. Rivanera D, Lorino G, Lilli D, Dicuonzo G, Mancini C. Evaluation of indeterminate sera for hepatitis C virus by assays using synthetic peptides. Eur J Epidemiol 1994; 10: 235-7.
25. Buffet C, Charnaux N, Laurent-Puig P, Chopineau S, Quichon JP, Briantais MJ, et al. Enhanced detection of antibodies to hepatitis C virus by use of a third-generation recombinant Immunoblot assay. J Med Virol 1994; 43: 259-61.
26. Zaaijer HL, Cuypers HTM, Reesink HW, Winkel IN, Gerken G, Lelie PN Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993; 341: 722-4.
27. French study group for the standardization of hepatitis C virus PCR. Improvement of hepatitis C virus RNA polymerase chain reaction through a multicentre quality control study. J Virol Methods 1994; 49: 79-88.
28. Dow BC, Follett EAC, Munro H, Buchanan I, Roy K, McOmish F, et al. Failure of 2nd- and 3rd-generation HCV ELISA and RIBA to detect HCV polymerase chain reaction-positive donations. Vox Sang 1994; 67: 236-7.
29. Sankary TM, Yang G, Romeo JM, Ulrich PP, Busch MP, Rawal BD, et al. Rare detection of hepatitis B and hepatitis C virus genomes by polymerase chain reaction in seronegative donors with elevated alanine aminotransferase. Transfusion 1994; 34: 656-60.
30. Halfon P, Pol S, Sayada C, Izopet J, Rostaing L, Ouzan D. Intérêt clinique de la recherche et de la quantification de l'ARN du virus de l'hépatite C chez les hémodialysés : proposition d'une stratégie diagnostique rationnelle. Néphrologie 1997; 18: 53-8.
31. Journal officiel de la République française, 12 août 1997; 11960-76.